Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Navis

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Diabetologia|June 16, 2011
Plasma procalcitonin and risk of type 2 diabetes in the general populationA Abbasi, E Corpeleijn, D Postmus, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 3, 2009
Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipientsD M Zelle, E Corpeleijn, R M van Ree, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuriaB K Mahmoodi, A B Mulder, F Waanders, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 27, 2014
Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipientsL C Baia, E Van den Berg, M G Vervloet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2006
The predictive value of renal vascular resistance for late renal allograft lossA P J de Vries, W J van Son, J J Homan van der Heide, et al.
Journal of Internal Medicine|October 15, 2013
Telomere length loss due to smoking and metabolic traitsJ Huzen, L S M Wong, D J van Veldhuisen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2018
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetesN Tofte, M Lindhardt, K Adamova, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Diabetologia|June 16, 2011
Plasma procalcitonin and risk of type 2 diabetes in the general populationA Abbasi, E Corpeleijn, D Postmus, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 3, 2009
Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipientsD M Zelle, E Corpeleijn, R M van Ree, et al.
Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuriaB K Mahmoodi, A B Mulder, F Waanders, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 27, 2014
Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipientsL C Baia, E Van den Berg, M G Vervloet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2006
The predictive value of renal vascular resistance for late renal allograft lossA P J de Vries, W J van Son, J J Homan van der Heide, et al.
Journal of Internal Medicine|October 15, 2013
Telomere length loss due to smoking and metabolic traitsJ Huzen, L S M Wong, D J van Veldhuisen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2018
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetesN Tofte, M Lindhardt, K Adamova, et al.
Pageof 7